Cargando…
Correction to: Predicting Drug–Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652258/ https://www.ncbi.nlm.nih.gov/pubmed/36112343 http://dx.doi.org/10.1007/s40262-022-01178-3 |
_version_ | 1784828429184532480 |
---|---|
author | Montanha, Maiara Camotti Fabrega, Francesc Howarth, Alice Cottura, Nicolas Kinvig, Hannah Bunglawala, Fazila Lloyd, Andrew Denti, Paolo Waitt, Catriona Siccardi, Marco |
author_facet | Montanha, Maiara Camotti Fabrega, Francesc Howarth, Alice Cottura, Nicolas Kinvig, Hannah Bunglawala, Fazila Lloyd, Andrew Denti, Paolo Waitt, Catriona Siccardi, Marco |
author_sort | Montanha, Maiara Camotti |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9652258 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-96522582022-11-15 Correction to: Predicting Drug–Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling Montanha, Maiara Camotti Fabrega, Francesc Howarth, Alice Cottura, Nicolas Kinvig, Hannah Bunglawala, Fazila Lloyd, Andrew Denti, Paolo Waitt, Catriona Siccardi, Marco Clin Pharmacokinet Correction Springer International Publishing 2022-09-16 2022 /pmc/articles/PMC9652258/ /pubmed/36112343 http://dx.doi.org/10.1007/s40262-022-01178-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Correction Montanha, Maiara Camotti Fabrega, Francesc Howarth, Alice Cottura, Nicolas Kinvig, Hannah Bunglawala, Fazila Lloyd, Andrew Denti, Paolo Waitt, Catriona Siccardi, Marco Correction to: Predicting Drug–Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling |
title | Correction to: Predicting Drug–Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling |
title_full | Correction to: Predicting Drug–Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling |
title_fullStr | Correction to: Predicting Drug–Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling |
title_full_unstemmed | Correction to: Predicting Drug–Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling |
title_short | Correction to: Predicting Drug–Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling |
title_sort | correction to: predicting drug–drug interactions between rifampicin and ritonavir-boosted atazanavir using pbpk modelling |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652258/ https://www.ncbi.nlm.nih.gov/pubmed/36112343 http://dx.doi.org/10.1007/s40262-022-01178-3 |
work_keys_str_mv | AT montanhamaiaracamotti correctiontopredictingdrugdruginteractionsbetweenrifampicinandritonavirboostedatazanavirusingpbpkmodelling AT fabregafrancesc correctiontopredictingdrugdruginteractionsbetweenrifampicinandritonavirboostedatazanavirusingpbpkmodelling AT howarthalice correctiontopredictingdrugdruginteractionsbetweenrifampicinandritonavirboostedatazanavirusingpbpkmodelling AT cotturanicolas correctiontopredictingdrugdruginteractionsbetweenrifampicinandritonavirboostedatazanavirusingpbpkmodelling AT kinvighannah correctiontopredictingdrugdruginteractionsbetweenrifampicinandritonavirboostedatazanavirusingpbpkmodelling AT bunglawalafazila correctiontopredictingdrugdruginteractionsbetweenrifampicinandritonavirboostedatazanavirusingpbpkmodelling AT lloydandrew correctiontopredictingdrugdruginteractionsbetweenrifampicinandritonavirboostedatazanavirusingpbpkmodelling AT dentipaolo correctiontopredictingdrugdruginteractionsbetweenrifampicinandritonavirboostedatazanavirusingpbpkmodelling AT waittcatriona correctiontopredictingdrugdruginteractionsbetweenrifampicinandritonavirboostedatazanavirusingpbpkmodelling AT siccardimarco correctiontopredictingdrugdruginteractionsbetweenrifampicinandritonavirboostedatazanavirusingpbpkmodelling |